Prevent efficacy: optimization of GEM models for high-risk cohorts of human pancreatic cystadenomas, ipmns, and panins progression to pdac.
Ended Awarded Last action
- Contract number
- HHSN26100004
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $598,567
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $598,566.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73117, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$786 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $599,353 |
About this award
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to the University of Oklahoma Health Sciences Center (OU HCSC) division of the University of Oklahoma. The $598,566.75 award is under the NCI's "PREVENT Cancer Program (PREVENT)" and aims to optimize Genomic Evidence Multiscale (GEM) models for predicting the progression of high-risk pancreatic lesions to pancreatic ductal adenocarcinoma (PDAC). The contract has a period of performance ending on September 23, 2018 and was not set aside for any small business category.
Quick answers
Who was awarded contract HHSN26100004?
HHSN26100004 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100004 worth?
The government has obligated $598,567 on HHSN26100004.
Is contract HHSN26100004 an order under another contract?
Yes. HHSN26100004 is a delivery order under HHSN261201500038I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100004 competed?
The extent of competition for HHSN26100004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award